- Home
- FLYX vs IPSC Comparison
FLYX vs IPSC Comparison
Compare FLYX & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLYX
- IPSC
- Stock Information
- Founded
- FLYX 2015
- IPSC 2019
- Country
- FLYX United States
- IPSC United States
- Employees
- FLYX N/A
- IPSC N/A
- Industry
- FLYX Blank Checks
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- FLYX Finance
- IPSC Health Care
- Exchange
- FLYX Nasdaq
- IPSC Nasdaq
- Market Cap
- FLYX 60.0M
- IPSC 48.2M
- IPO Year
- FLYX N/A
- IPSC 2021
- Fundamental
- Price
- FLYX $3.17
- IPSC $0.53
- Analyst Decision
- FLYX
- IPSC Strong Buy
- Analyst Count
- FLYX 0
- IPSC 5
- Target Price
- FLYX N/A
- IPSC $3.33
- AVG Volume (30 Days)
- FLYX 7.7K
- IPSC 719.1K
- Earning Date
- FLYX 05-13-2025
- IPSC 05-15-2025
- Dividend Yield
- FLYX N/A
- IPSC N/A
- EPS Growth
- FLYX N/A
- IPSC N/A
- EPS
- FLYX N/A
- IPSC N/A
- Revenue
- FLYX $335,427,000.00
- IPSC $114,898,000.00
- Revenue This Year
- FLYX $28.47
- IPSC $833.10
- Revenue Next Year
- FLYX $22.44
- IPSC N/A
- P/E Ratio
- FLYX N/A
- IPSC N/A
- Revenue Growth
- FLYX 5.38
- IPSC 8286.72
- 52 Week Low
- FLYX $1.79
- IPSC $0.34
- 52 Week High
- FLYX $7.68
- IPSC $3.46
- Technical
- Relative Strength Index (RSI)
- FLYX 59.46
- IPSC 46.73
- Support Level
- FLYX $2.60
- IPSC $0.48
- Resistance Level
- FLYX $3.39
- IPSC $0.59
- Average True Range (ATR)
- FLYX 0.20
- IPSC 0.04
- MACD
- FLYX 0.04
- IPSC -0.00
- Stochastic Oscillator
- FLYX 72.52
- IPSC 34.62
About FLYX flyExclusive Inc.
flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 100 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.